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F ish, in particular genetically modifiedzebrafish, are important model organ-isms for biomedical research and
research into human diseases. The European
Directive 2010/63/EU on the protection of
animals used for scientific purposes entails
that genetically altered vertebrates need to be
assessed for pain, suffering, distress, or last-
ing harm (collectively referred to here as
“adverse phenotypes”). If such phenotypes
are present, maintenance of genetically
altered animals is now subject to project
authorization. As genetically altered fish are
commonly imported into the EU and
exchanged between laboratories, fish lines
should be classified consistently. To this end,
the German Federal Institute for Risk Assess-
ment (BfR) organized a workshop in June
2015 to define criteria for assessing genetically
induced adverse phenotypes in fish. Here, we
describe the Workshop’s considerations that
guided the design of dedicated evaluation
sheets. We believe that broad use of these
evaluation sheets and the explanatory notes
associated with them can contribute substan-
tially to harmonizing how teleost fish pheno-
types are assessed across Europe. In our view,
this would protect both animal welfare and
ensure progress in biomedical research.
Across Europe, welfare of laboratory
animals is a growing public concern
(Ormandy & Schuppli, 2014). Yet, a majority
of European citizens is willing to accept
animal experimentation to promote biomed-
ical progress (http://ec.europa.eu/public_
opinion/archives/ebs/ebs_340_en.pdf). The
spirit of the European Directive 2010/63/EU
on the protection of animals used for scien-
tific purposes, which has been implemented
by all EU member states only last year,
reflects these attitudes: Recital 10 of the Direc-
tive states that the final goal is to phase out
all animal testing, but it also acknowledges
that animal experiments are still needed to
advance research and to safeguard human,
animal, and environmental health (http://
eur-lex.europa.eu/legal-content/EN/TXT/PDF/
?uri=CELEX:32010L0063&from=EN). To that
end, all member states agreed on a high stan-
dard of animal welfare in research and to
apply the 3R principle (replacement, reduc-
tion, and refinement) wherever possible.
The Directive now stipulates that breed-
ing of genetically altered animals in Europe
is subject to project authorization if these
animals are likely to experience pain, suf-
fering, distress, or lasting harm as a result of
the genetic modification. Scientists therefore
have to document whether and to what
degree genetically altered animals show an
adverse phenotype. This means that, on the
one hand, the total number of genetically
altered animals that experience adverse
phenotypes is documented for the first time.
On the other hand, scientists have to put
more effort and resources into analyzing and
documenting the effects of genetic manipula-
tions on animal phenotypes. However,
scientifically sound standards are needed on
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how to objectively, consistently, and effi-
ciently evaluate phenotypes in order to make
the resulting data reliable and the assess-
ment feasible. At the same time, the evalua-
tion procedures have to avoid additional
distress for the animals and should not
unnecessarily hamper scientific progress.
When thinking of animal in research,
rodents, dog, cats, and monkeys come to
mind. However, according to the European
Commission’s statistic report (http://eur-lex.
europa.eu/legal-content/EN/TXT/PDF/?uri=
CELEX:52013DC0859&from=EN), fish rank
third behind mice and rats on the list report-
ing the numbers of animals used for
research purposes. Moreover, while the
number of mice and rats has slightly
decreased during recent years, the total
number of laboratory fish used in develop-
mental biology and other areas of basic
biomedical research increased by about 29%
from 2008 to 2011. This trend can be partic-
ularly attributed to the fact that fish, espe-
cially zebrafish and medaka, are valuable
transgenic model organisms for human
diseases (Lieschke & Currie, 2007) and have
a firmly established role in the pharmaceuti-
cal industry (http://www.roche.com/rese
arch_and_development/drawn_to_science/
zebrafish.htm). Contributing to this increase
in numbers is the fact that the use of fish
instead of rodents is regarded as a refine-
ment in the sense of the 3R, as Article 13 of
the Directive requires using species with the
lowest capacity to experience pain, suf-
fering, distress, or lasting harm (http://eur-
lex.europa.eu/legal-content/EN/TXT/PDF/?
uri=CELEX:32010L0063&from=EN). More-
over, using fish larvae before they start to
feed independently has become an alterna-
tive method for many scientific studies,
because the eleutheroembryo stages of fish
do not fall within the regulations of the
Directive (Stra¨hle et al, 2012). The availabil-
ity of new genome editing techniques, such
as CRISPR/Cas9, is likely to further increase
the number of genetically modified labora-
tory fish in the coming years.
P utting the obligations of the Directiveinto practice, it becomes evident thatthere is a gap between the political
demand to improve animal welfare and the
lack of scientifically sound biomedical indi-
cators for animal welfare. The Directive
requires scientists to determine whether and
to what extent animals suffer or feel pain or
distress, but it does not provide objective
criteria to evaluate such conditions. A close
collaboration between scientists, animal
welfare officers, lawyers, and members of
the executive authorities is needed to find a
solution that efficiently protects animals,
offers a high level of legal security, and can
be implemented as efficiently as possible for
the sake of ensuring scientific progress.
Pursuing such an interdisciplinary approach,
the BfR brought together the expertise of
scientists and executive authorities in 2013
to compile workable documents to assess
welfare of genetically altered mice and rats
(Grune et al, 2014). These documents are
now used in Germany and have successfully
harmonized the evaluation process of
research projects that use genetically altered
rodents. However, these documents cannot
be easily transferred to other species: the dif-
ferent physiology and behavior make it
necessary to define species-specific criteria
for assessing animal welfare.
A similar regulatory framework for fish
has so far not been developed, and, apart
from guidelines for toxicity testing in fish, no
feasible concepts are available to assess fish
well-being and adverse phenotypes. Thus,
the BfR initiated a Workshop in June 2015 to
compile workable documents for the assess-
ment of adverse phenotypes of genetically
altered teleost fish (http://www.bfr.bund.de/
cm/349/severity-assessment-of-genetically-
altered-fish-bony-fish-teleost-fish.pdf). The
participants were scientists with expertise in
the field of physiology, pathology and behav-
ior of laboratory fish, legal experts, and
veterinary specialists for aquaculture and for
laboratory animal research, for fish facility
management, for pharmacology and toxicol-
ogy, as well as representatives of the respon-
sible executive authorities in Germany. They
were asked to define guiding principles,
criteria, and evaluation sheets to enable a
scientifically and legally sound evaluation
of teleost fish phenotypes for the purpose
of fulfilling the EU Directive’s requirements
and its specific implementation in German
law. With this in mind, the Workshop
discussed a number of general principles
that should guide the recommended screen-
ing approach to detect adverse phenotypes.
F irst, criteria for assessing adversephenotypes should cover all teleostfish species used in biomedical
research. Given that the new gene editing
techniques are generally applicable in tele-
osts, the commonly used zebrafish and
medaka are not the only fish species in need
of assessment. This implied that, for exam-
ple, the workshop recommendations had to
take into account different sizes (e.g., zebra-
fish vs. cichlids), behaviors (e.g., swarm vs.
single swimming), physiologies (e.g., speed
of larval development), and to propose crite-
ria that live up to the requirements of assess-
ing different species.
Second, the participants agreed that,
based on the present scientific data, no final
decision can be made as to the extent to
which fish are able to consciously feel pain.
A consensus was reached that several
neuroanatomical structures exist in fish to
respond to noxious events by inducing
avoidance reflexes. This response, however,
has to be clearly distinguished from the
conscious notion of pain. Various nocicep-
tive peripheral pathways, containing Ad-
and, to a lesser extent, C-fibers, have been
demonstrated in some teleost fish species,
such as the rainbow trout and carp. The
existence of neuroanatomical pathways from
the periphery to the teleost brain is also
undisputed. However, there is an ongoing
debate as to whether fish are able to
perceive pain at a higher level (see Rose
et al, 2014; Sneddon, 2015). The pallium,
which, as the cerebral cortex, is necessary
for conscious perception of pain in
mammals, is present in fish but is not as dif-
ferentiated as in humans. An amygdala, in
mammals part of the limbic system and
important for emotional processing of a
stimulus (Neugebauer, 2015), is present in
fish, but thalamo-amygdalar pathways that
may transmit sensory stimuli are structured
differently as studied so far (Mueller, 2012),
and thalamo-cortico-amygdalar pathway-
equivalent circuits have not been identi-
fied.
As there are around 30,000 different
teleost fish species, which differ profoundly
in their anatomy, physiology, and behavior,
it also is clear that evidence derived in one
species cannot be easily transferred to
another. Furthermore, it would be difficult
to objectively measure pain, as the behav-
ioral responses to a noxious stimulus might
differ between species owing to their dif-
ferent physiological and behavioral baseline
(see Sneddon, 2015). For these reasons, the
Workshop participants decided that for
assessing adverse phenotypes in teleost fish,
the focus should lie on the occurrence of
“lasting harm” as an objectively measurable
parameter, and secondly on the occurrence
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of suffering and distress, which is less easy
to ascertain.
Third, the participants agreed that some
criteria, which are important for the assess-
ment of welfare in rodents, cannot be imple-
mented in the same form for fish. For
example, a reproduction rate standardized
across breeding facilities can be a valuable
indicator for well-being in mice and rats, but
it is difficult to use this criterion for fish.
Whereas the survival rate of mice from birth
till weaning is about 80% in captivity, this
rate is much more variable in fish, which
use a fundamentally different reproduction
strategy that is much more dependent on
external influences: In zebrafish, for
instance, hundreds of externally developing
larvae are left to their own device or even
cannibalized by their parents if not sepa-
rated. Moreover, the speed of development
and growth of fish highly depends on exter-
nal factors such as water temperature, and
quality and amount of food (see Singleman
& Holtzman, 2014). Hence, phenotypic
assessment needs to be done against an
“internal standard” of a given facility. As a
consequence, institutions maintaining genet-
ically altered fishes should be aware of the
“normal” development and behavior of the
respective wild-type under their specific
environmental conditions, and changes in
genetically modified fish lines should be
related to these wild-type parameters.
Finally, the specific physiology of fish
species results in somewhat different
expectations for the frequency of genetically
caused adverse phenotypes. For one, consid-
ering the “lasting nature of harm”, one has
to be aware that fish have powerful regener-
ative properties and can replace damaged
tissues of the heart, fins, spinal cord, brain,
and many sensory organs during adult life,
which can compensate for genetically
caused impairments.
In addition, as a prime organism for
in vivo imaging due to its initial transparency,
genetically altered zebrafish are often gener-
ated for observational experiments. This
means that many fish lines only carry inser-
tions of reporter genes in their genomes,
coding, for instance, for fluorescent proteins
or transactivators to control expression of
such marker proteins. These insertions are
experimentally required to be phenotypically
inert. Typically, new fish lines are screened at
embryonic or early larval stage before inde-
pendent feeding, that is, to a time point where
the Directive does not yet apply, and are
excluded from further breeding. Indeed,
researchers of the Workshop reported that
such reporter lines—as well as the vast
majority of heterozygous mutations identified
in large-scale genetic screens (Driever et al,
1996)—are less likely to show evidence of
harm. It can therefore be expected that,
compared to rodents, a smaller fraction of
new fish lines with an adverse phenotype will
be detected, necessitating an evaluation
approach that is tailored to this high-
throughput/low-gain setting.
B ased on these principles, three specificrecommendations were adopted andguided the design of the evaluation
sheets. First, genetically altered fish should be
assessed at two stages, initially as larvae at
the time point of independent feeding—when
they first enter the Directive’s legal realm—
and again as adult, sexually mature individu-
als. Zebrafish larvae are known to feed inde-
pendently only at 120 hours post-fertilization
(hpf). However, the time point for larvae to
feed independently generally depends on vari-
ous factors: nearly complete yolk consump-
tion, free active swimming, the morphology
of the digestive organs, and the ability to
incorporate food (see Stra¨hle et al, 2012).
Sexual maturity can be defined by fully
differentiated testes or gonads and the
production of viable gametes as well as the
occurrence of secondary sexual characteris-
tics. Most zebrafish reach sexual maturity at
a standard length of 18 mm (see Parichy
et al, 2009). From that period onwards,
zebrafish just grow in size, but remain
anatomically stable. Since aging processes
start around 18 months (Gerhard et al,
2002), the Workshop participants
recommended that sexually mature zebra-
fish are assessed at a time point between 90
and 120 days post-fertilization (dpf).
As different fish species vary highly in
their speed of development, the two time
points need to be determined individually
for each teleost species. In addition, being
poikilothermic animals, fish development also
No authorization for 
breeding required
Breeding requires 
authorization by
executive authority
SEVERITY ASSESSMENT
FINAL ASSESSMENT – DECISION 
ON DEGREE OF SEVERITY 
Teleost of unknown 
adverse/non-adverse 
phenotype
?
No adverse phenotype
Adverse phenotype
1 Larvae at time point 
 of independent feeding
2 Adult, sexually mature fish
?
?
Figure 1. Evaluation process for genetically altered teleost fish with an unknown non-adverse/adverse phenotype.
Breeding of genetically altered animals needs to be authorized by the executive authority until a non-adverse phenotype has been confirmed.
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depends, in addition to water temperature,
on several environmental factors such as
feed and stocking density. This implies that
the two developmental stages have to be
determined for each species at each facility.
Second, in accordance with the 3R princi-
ple, no additional fishes should be bred for
the assessment, and the animals should be
assessed by observation in their tanks undis-
turbed (i.e., by adspection only) to avoid
any additional stress. As larvae cannot be
permanently marked, different animals can
be used for assessment at the two different
time points.
Third, a representative number of fish
should be observed, which again will depend
on the fish species. Keeping the number of
fish progeny in mind, which differs highly
from rodents, the number has to be as practi-
cal as possible for the person carrying out the
observation. At the same time, the number
has to provide enough data to reliably predict
whether an adverse phenotype can be
expected in the genetically altered fish line.
As it is impossible to assess all larvae of a
clutch at a glance, the participants decided to
analyze a minimum of 10 larvae at the same
time. Experience shows that under standard
breeding conditions, larvae from one clutch
can display abnormalities that cannot specifi-
cally be traced back to the genetic manipula-
tion. Thus, it is recommended that 20 larvae
from at least two clutches are analyzed as
among 20 genetically modified larvae, there is
a 94% probability to detect an adverse pheno-
type twice even if only one quarter of the
larvae is affected. Based on the recommenda-
tion of the EU working document on geneti-
cally altered animals (http://ec.europa.eu/
environment/chemicals/lab_animals/pdf/cor
rigendum.pdf), it is suggested that at least 7
adult and sexually mature fish should be
assessed whether no sex-specific differences
can be expected.
Taken together, this means that any fish
line of any given genotype with unclear
phenotype will need to be scored twice
following a scheme as outlined in Fig 1.
Given the large number of newly generated
fish lines and that various people with dif-
ferent backgrounds (scientists, animal care-
takers, and animal welfare officers) will be
involved in the assessment, the participants
tried to keep the evaluation sheets and their
explanatory notes as informative and simple
as possible. The Workshop drafted three
forms for the phenotypic assessment of
genetically altered teleost fish: two forms for
evaluating the two time points with age-
matched criteria, and a summary sheet for
the executive authorities. More information
in the form of an explanatory note is now
available in German and English on the
website of the BfR (http://www.bfr.bund.de/
cm/349/severity-assessment-of-genetically-
altered-fish-bony-fish-teleost-fish.pdf).
O verall, the BfR workshops to gener-ate consensus recommendationsand evaluation sheets for animals
ranging from fish to rodents show that only
an interinstitutional and interdisciplinary
approach focused on finding practical solu-
tions for implementing the EU Directive can
ensure a high level of acceptance within the
scientific community and executive authori-
ties. We believe that the general example of
the process outlined here, as well as the
specific results obtained with regard to eval-
uating harm in fish, might be of value across
the EU. Obviously, the specific recommenda-
tions can only reflect the present state of
scientific knowledge and need to be regu-
larly adapted to new findings—ideally again
using an interdisciplinary approach. To
improve the welfare of laboratory fish on a
scientific basis requires more fundamental
research on the neurobiology, physiology,
and behavior of such animals. Only with
such objective information at hand, and in a
continuous dialogue with the public who
demands the dual assurance of animal
welfare and biomedical progress, science
can proceed within a well-ordered legal
framework that is trusted by citizens who
demand regulation and oversight, the execu-
tive bodies that execute the law, and the
scientists who are subjected to it.
Conflict of interest
MB is employed by Tecniplast Germany. All other
authors declare that they have no conflict of
interest.
References
Driever W, Solnica-Krezel L, Schier AF,
Neuhauss SC, Malicki J, Stemple DL, Stainier
DY, Zwartkruis F, Abdelilah S, Rangini Z, Belak
J, Boggs C (1996) A genetic screen for
mutations affecting embryogenesis in
zebrafish. Development 123:
37 – 46
Gerhard GS, Kauffman EJ, Wang X, Stewart R,
Moore JL, Kasales CJ, Demidenko E, Cheng KC
(2002) Life spans and senescent
phenotypes in two strains of Zebrafish
(Danio rerio). Exp Gerontol 37:
1055 – 1068
Grune B, Hensel A, Schonfelder G (2014) Animal
welfare: rules for assessing pain in lab animals.
Nature 512: 28
Lieschke GJ, Currie PD (2007) Animal models of
human disease: zebrafish swim into view. Nat
Rev Genet 8: 353 – 367
Mueller T (2012) What is the Thalamus in
Zebrafish? Front Neurosci 6: 64
Neugebauer V (2015) Amygdala pain
mechanisms. Handb Exp Pharmacol 227:
261 – 284
Ormandy EH, Schuppli CA (2014) Public attitudes
toward animal research: a review. Animals
(Basel) 4: 391 – 408
Parichy DM, Elizondo MR, Mills MG, Gordon TN,
Engeszer RE (2009) Normal table of
postembryonic zebrafish development:
staging by externally visible anatomy of
the living fish. Dev Dyn 238: 2975 – 3015
Rose JD, Arlinghaus R, Cooke SJ, Diggles BK,
Sawynok W, Stevens ED, Wynne CDL (2014)
Can fish really feel pain? Fish Fish 15:
97 – 133
Singleman C, Holtzman NG (2014) Growth and
maturation in the zebrafish, Danio rerio: a
staging tool for teaching and research.
Zebrafish 11: 396 – 406
Sneddon LU (2015) Pain in aquatic animals. J Exp
Biol 218: 967 – 976
Strähle U, Scholz S, Geisler R, Greiner P, Hollert H,
Rastegar S, Schumacher A, Selderslaghs I, Weiss
C, Witters H, Braunbeck T (2012) Zebrafish
embryos as an alternative to animal
experiments–a commentary on the definition
of the onset of protected life stages in
animal welfare regulations. Reprod Toxicol 33:
128 – 132
License: This is an open access article under the
terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 4.0 License, which
permits use and distribution in any medium,
provided the original work is properly cited, the use
is non-commercial and no modifications or adapta-
tions are made.
The EMBO Journal Vol 35 | No 11 | 2016 ª 2016 The Authors
The EMBO Journal Evaluating adverse phenotypes in teleost fish Bettina Bert et al
1154
